Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Short-Term Debt : ¥17,874 Mil (As of Mar. 2025)

View and export this data going back to 1998. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Short-Term Debt?

Shanghai Fosun Pharmaceutical (Group) Co's Short-Term Debt for the quarter that ended in Mar. 2025 was ¥17,874 Mil.

Shanghai Fosun Pharmaceutical (Group) Co's quarterly Short-Term Debt increased from Sep. 2024 (¥18,680 Mil) to Dec. 2024 (¥18,711 Mil) but then declined from Dec. 2024 (¥18,711 Mil) to Mar. 2025 (¥17,874 Mil).

Shanghai Fosun Pharmaceutical (Group) Co's annual Short-Term Debt increased from Dec. 2022 (¥11,932 Mil) to Dec. 2023 (¥14,728 Mil) and increased from Dec. 2023 (¥14,728 Mil) to Dec. 2024 (¥18,711 Mil).

Shanghai Fosun Pharmaceutical (Group) Co Short-Term Debt Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Short-Term Debt Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

7,915.98

9,420.13

11,931.54

14,728.45

18,711.32

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Debt	Get a 7-Day Free Trial															15,532.62	17,317.21	18,679.64	18,711.32	17,874.46

Shanghai Fosun Pharmaceutical (Group) Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Shanghai Fosun Pharmaceutical (Group) Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » Short-Term Debt

Traded in Other Exchanges

SFOSF:USA 02196:Hong Kong 08HH:Germany

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.

Executives

Yao Fang	Director
Wu Yi Fang	Director
Wen De Yong	Directors, senior managers
Guan Xiao Hui	Director
Wang Ke Xin	Director
Bao Qin Gui	senior management
Mei Jing Ping	senior management
Li Sheng Li	senior management
Feng Rong Li	senior management
Wang Dong Hua	senior management
Dong Xiao Xian	senior management
Su Li	senior management
Zhu Yue	senior management
Chen Yu Qing	senior management
Hu Hang	senior management

Shanghai Fosun Pharmaceutical (Group) Co Headlines

No Headlines